Connect with us

Hi, what are you looking for?

Smart Investment StepsSmart Investment Steps

Investing

Trump amends executive order raising China tariffs to 20% over ‘failure to address’ fentanyl crisis

The White House announced Monday that China will face increased tariffs, citing the ongoing fentanyl crisis in the U.S. as the main reason for the decision.

In a post on X, the Rapid Response 47 account shared the text of an executive order (EO) signed by President Donald Trump on Monday. The Chinese government will now face 20% tariffs ‘over their failure to address the fentanyl pouring into our country,’ the EO stated.

The tariffs against China, which were originally only 10%, will go into effect on Tuesday. In Monday’s order, Trump said that the Chinese government has failed ‘to blunt the sustained influx of synthetic opioids, including fentanyl, flowing from [their country],’ and that such failure constitutes an ‘unusual and extraordinary threat.’

Trump also said that the crisis jeopardizes the ‘national security, foreign policy, and economy of the United States.’

‘I have determined that the [People’s Republic of China] has not taken adequate steps to alleviate the illicit drug crisis through cooperative enforcement actions, and that the crisis described in Executive Order 14195 has not abated,’ the order read. 

‘In recognition of the fact that the PRC has not taken adequate steps to alleviate the illicit drug crisis, section 2(a) of Executive Order 14195 is hereby amended by striking the words ‘10 percent’ and inserting in lieu thereof the words ‘20 percent’.’

The Trump administration is already imposing 25% tariffs on Canadian and Mexican goods, which were announced last month and will also go into effect on Tuesday. On Monday, Peter Navarro, the White House senior counselor on trade and manufacturing, defended the tariffs to CNBC and argued that the issue ‘starts in communist China with the precursor chemicals.’

‘It comes into Mexico, and they make the fentanyl. But they also have these pill presses. So they do the counterfeits,’ Navarro explained. ‘And they’re using Canada as a transit hub and secondary point to manufacture as well. So this is a Canada-Mexico-China thing.’

The Chinese government has opposed the tariffs since they were announced. In a Feb. 1 statement, China’s Ministry of Foreign Affairs claimed that China is ‘one of the world’s toughest countries on counternarcotics both in terms of policy and its implementation.’

‘Additional tariffs are not constructive and bound to affect and harm the counternarcotics cooperation between the two sides in the future,’ the statement read. ‘China calls on the U.S. to correct its wrongdoings, maintain the hard-won positive dynamics in the counternarcotics cooperation, and promote the steady, sound and sustainable development of China-U.S. relationship.’

Fox News Digital’s Anders Hagstrom contributed to this report.

This post appeared first on FOX NEWS

Enter Your Information Below To Receive Latest News and Articles




    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

    You May Also Like

    Stock

    JetBlue Airways is talking with “multiple airlines” about a potential new partnership after federal judges struck down two previous deals, the carrier’s president said Wednesday....

    Stock

    Airbus could prioritize deliveries to its non-U.S. customers if tariffs disrupt the European plane maker’s imports stateside, CEO Guillaume Faury said Thursday. “We have a...

    Stock

    Direct-to-consumer footwear brand Rothy’s just recorded its best year on record after the company appointed retail veteran Jenny Ming, one of the co-founders of Old...

    Stock

    An “embarrassment of riches” at the box office could fuel a $1.2 billion year for IMAX, CEO Rich Gelfond told CNBC on Friday. That volume...

    Disclaimer: smartinvestmentsteps.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2024 smartinvestmentsteps.com